Drugs -- Prices -- United States
Resource Information
The concept Drugs -- Prices -- United States represents the subject, aboutness, idea or notion of resources found in Biddle Law Library- University of Pennsylvania Law School.
The Resource
Drugs -- Prices -- United States
Resource Information
The concept Drugs -- Prices -- United States represents the subject, aboutness, idea or notion of resources found in Biddle Law Library- University of Pennsylvania Law School.
- Label
- Drugs -- Prices -- United States
120 Items that share the Concept Drugs -- Prices -- United States
Context
Context of Drugs -- Prices -- United StatesSubject of
No resources found
No enriched resources found
- A Report on 1993 pharmaceutical price inflation : drug prices for older Americans still increasing much faster than inflation : staff report
- A Status report : accessibility and affordability of prescription drugs for older Americans (annotated) : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate
- A Status report, accessibility and affordability of prescription drugs for older Americans : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate
- A prescription for savings : reducing drug costs to Medicare : hearing before the Special Committee on Aging, United States Senate, One Hundred Twelfth Congress, first session, Washington, DC, July 21, 2011
- Administered Prices : hearings before the United States Senate Committee on the Judiciary, Subcommittee on Antitrust and Monopoly, Eighty-Sixth Congress, second session, Part 23, Administered Prices in the Drug Industry
- Administered Prices : hearings before the United States Senate Committee on the Judiciary, Subcommittee on Antitrust and Monopoly, Eighty-Sixth Congress, second session, on Feb. 25, 26, Apr. 12-15, 1960, Part 18, Administered Prices in the Drug Industry (General: Physicians and Other Professional Authorities)
- Allegations of waste, fraud, and abuse in pharmaceutical pricing : financial impacts on federal health programs and the federal taxpayer : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, February 9, 2007
- Blue Cross and Blue Shield : change in pharmacy benefits affects federal enrollees : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Civil Service, Committee on Government Reform and Oversight, House of Representatives
- Comparing Medicare and Medicaid Drug Pricing : Apples, Oranges and "Windfalls"
- Comparison of Medicare Drug Price Analyses : Fact Sheet
- Competitive Problems in the Drug Industry : hearings before the United States Senate Select Committee on Small Business, Subcommittee on Monopoly, Ninetieth Congress, first session and Ninetieth Congress, second session, on Dec. 14, 19, 1967; Jan. 18, 19, 25, 1968, Part 5
- Creating and Restoring Equal Access to Equivalent Samples Act of 2019 : report (to accompany H.R. 965) (including cost estimate of the Congressional Budget Office)
- DOD Pharmacy Benefits Program : Reduced Pharmacy Costs Resulting from the Uniform Formulary and Manufacturer Rebates
- DOD and VA pharmacy : progress and remaining challenges in jointly buying and mailing out drugs : report to Congressional requesters
- Democrats Examine Ways To Lower Medicare Drug Prices
- Designing a twenty-first century Medicare prescription drug benefit : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, April 8, 2003
- Drug prices : effects of opening federal supply schedule for pharmaceuticals are uncertain : report to congressional committees and the Administrator of General Services
- Drug prices paid by DOD and VA are, on average, lower than those certified to HCFA as best price
- Drug pricing : poor prescription for consumers and taxpayers? : hearing before the Committee on Governmental Affairs, United States Senate, One Hundred Third Congress, second session, July 27, 1994
- Drug safety and pricing : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... June 13, 2000
- Drug safety and pricing : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... June 13, 2000
- Drug shortage crisis : lives are in the balance : hearing before the Subcommittee on Health Care, District of Columbia, Census, and the National Archives of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Twelfth Congress, first session, November 30, 2011
- Drug shortages : why they happen and what they mean : hearing before the Committee on Finance, United States Senate, One Hundred Twelfth Congress, first session, December 7, 2011
- Drug shortages, threat to public health persists, despite actions to help maintain product availability : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives
- Drug wars : how big pharma raises prices and keeps generics off the market
- Earning a failing grade : a report card on 1992 drug manufacturer price inflation : staff report to the Special Committee on Aging, United States Senate
- Enhancing Medicare for the 21st century : a prescription benefit for seniors : hearing before the Special Committee on Aging, United States Senate, One Hundred Eighth Congress, first session, St. Louis, MO, August 27, 2003
- Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, generic drug entry prior to patent expiration : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 13 and October 10, 2002
- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship
- Federal drug prices : effects of opening the pharmaceutical schedule are uncertain : statement of Bernice Steinhardt, Director, Health Services Quality and Public Health Issues, Health, Education, and Human Services Division, before the Subcommittee on Health, Committee on Veterans' Affairs, House of Representatives
- Full committee hearing on Medicaid drug reimbursements : are CMS cuts bad medicine for small businesses and beneficiaries?
- GAO : Medicare's Communications to Beneficiaries of the Prescription Drug Benefit Could Be Improved, Fact Sheet
- Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016
- Generic entry and the pricing of pharmaceuticals
- Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002
- Generic substitution and prescription drug prices : economic effects of state drug product selection laws
- Impact of Medicare Drug Plan Restrictions on Seniors : Case Studies
- Implications of the Medicare prescription drug benefit for state budgets
- Implications of the medicare prescription drug benefit for dual eligibles and state medicaid programs
- Increasing Transparency in the Pricing of Health Care Services and Pharmaceuticals : CBO Economic and Budget Issue Brief
- International prescription drug parity : are Americans being protected or gouged? : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, April 3, 2003
- International prescription drug prices : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, first session, February 22, 1993
- International trade and pharmaceuticals : joint hearing before the Subcommittee on International Trade and the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, April 27, 2004
- Internet pharmacy and drug importation : exploring risks and benefits : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, January 26, 2005
- Issues in designing a prescription drug benefit for Medicare
- Lessons learned : the Department of Veterans Affairs prescription drug purchasing program : hearing before the Subcommittee on National Security, Veterans Affairs, and International Relations of the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, second session, July 22, 2002
- Lessons learned : the Department of Veterans Affairs prescription drug purchasing program : hearing before the Subcommittee on National Security, Veterans Affairs, and International Relations of the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, second session, July 22, 2002
- Medicare : information on highest-expenditure Part B drugs : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives
- Medicare : payments for covered outpatient drugs exceed providers' cost
- Medicare : payments for covered outpatient drugs exceed providers' costs : report to Congressional committees
- Medicare Drug Card Prices Remain High
- Medicare Drug Plan Prices Are Higher Than Medicare Drug Card Prices
- Medicare Drug Plan Prices Are Increasing Rapidly
- Medicare Drug Plans : Restrictions on Access to Formulary Drugs
- Medicare Part B drugs : CMS data source for setting payments is practical but concerns remain : testimony before the Subcommittee on Health, Committee on Ways and Means, House of Representatives
- Medicare Part B drugs : program payments should reflect market prices
- Medicare Part D : Drug Pricing and Manufacturer Windfalls
- Medicare Part D Prescription Drug Coverage : Federal Oversight of Reported Price Concessions Data
- Medicare Part D, prescription drug benefit : increasing use and access of affordable prescription drugs : a report of the Special Committee on Aging, United States Senate
- Medicare drug benefit : retiree provisions
- Medicare drug reimbursements : a broken system for patients and taxpayers : joint hearing before the Subcommittee on Health and the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, September 21, 2001
- Medicare hospital pharmaceuticals : survey shows price variation and highlights data collection lessons and outpatient rate-setting challenges for CMS : report to congressional committees
- Medicare payments for currently covered prescription drugs : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, second session, October 3, 2002
- Medicare prescription drug benefit : hearing before the Committee on Finance, United States Senate, One Hundred Sixth Congress, first session, June 23, 1999
- Medicare prescription drug benefit : low-income provisions
- Medicare prescription drug benefit : review and oversight : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, May 8, 2007
- Medicare's new prescription drug coverage : a major step forward, but big problems still exist : staff report to the Special Committee on Aging, United States Senate
- Medicare-endorsed prescription drug discount card : their impact on small business : hearing before the Committee on Small Business, House of Representatives, One Hundred Seventh Congress, first session, Washington, DC, October 25, 2001
- New Medicare Drug Cards Offer Few Discounts
- Oversight Hearing on Providing Relief to Seniors Who Have Fallen into the Prescription Drug "Donut Hole"
- Paid to prescribe? : exploring the relationship between doctors and the drug industry : hearing before the Special Committee on Aging, United States Senate, One Hundred Tenth Congress, first session, Washington, DC, June 27, 2007
- Patents and drug information
- Patient safety and quality issues in end stage renal disease treatment : hearing before the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, second session, December 6, 2006
- Pay to delay : are patent settlements that delay generic drug market entry anticompetitive? : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, June 3, 2009
- Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, January 17, 2007
- Pharmaceutical costs : an international comparison of government policies
- Pharmaceutical marketplace reform : is competition the right prescription? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, November 16, 1993
- Pharmaceutical pricing and patent law
- Pharmacy benefit managers
- Pharmacy benefit managers : early results on ventures with drug manufacturers : statement of John C. Hansen, Assistant Director, Health Financing and Public Health Issues, Health, Education, and Human Services Division, before the Committee on Insurance, California State Senate
- Policy implications of pharmaceutical importation for U.S. consumers : hearing before the Subcommittee on Interstate Commerce, Trade, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Tenth Congress, first session, March 7, 2007
- Prescription Drug Pricing in the Private Sector : CBO Paper
- Prescription Drugs : Trends in Usual and Customary Prices for Drugs Frequently Used by Medicare and Non-Medicare Health Insurance Enrollees
- Prescription drug costs : a bitter pill to swallow : joint hearing before the Subcommittee on Housing and Consumer Interests and the Select Committee on Aging, House of Representatives, One Hundred Second Congress, second session, September 28, 1992, Logansport, IN
- Prescription drug costs : the growing burden for older Americans : hearing before the Special Committee on Aging, United States Senate, One Hundredth Congress, first session, Little Rock, AR, August 27, 1987
- Prescription drug costs : what drives increases? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, 106th Congress, 2nd session ... July 18, 2000
- Prescription drug issues in the Department of Veterans Affairs : hearing before the Committee on Veterans' Affairs, United States Senate, One Hundred Seventh Congress, first session, July 24, 2001
- Prescription drug prices : are we getting our money's worth? : a majority staff report of the Special Committee on Aging, United States Senate
- Prescription drug prices : official index overstates producer price inflation : report to the Chairman, Special Committee on Aging, U.S. Senate
- Prescription drug prices : outpricing older Americans : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Bangor, Maine, April 14, 1993
- Prescription drug pricing : implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives
- Prescription drug pricing and negotiation : overview and economic perspectives for the Medicare prescription drug benefit : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, January 11, 2007
- Prescription drug shortages : examining a public health concern and potential solutions : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session ... December 15, 2011
- Prescription drugs : is there a cure for the costs? : hearing before the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred Second Congress, second session, January 16, 1992, Vancouver, WA
- Prescription drugs : oversight of drug pricing in federal programs : testimony before the Committee on Oversight and Government Reform, House of Representatives
- Prescription drugs : price trends for frequently used brand and generic drugs from 2000 through 2004 : report to congressional requesters
- Prescription drugs and the elderly : the high cost of growing old : hearing before the Special Committee on Aging, United States Senate, One hundredth Congress, first session, Washington, DC, July 20, 1987
- President Bush's proposed medicare-endorsed drug discount card program : status and issues
- Prices for brand-name drugs under selected federal programs
- Pricing of drugs codeveloped by federal laboratories and private companies : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Washington, DC, January 25, 1993
- Purple Book Continuity Act of 2019 : report (to accompany H.R. 1520) (including cost estimate of the Congressional Budget Office)
- Reimbursement and access to prescription drugs under Medicare part B : hearing before the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Seventh Congress, second session, March 14, 2002
- Requiring disclosure of gifts and payments to physicians : state effots and a legal analysis of potential federal action
- Seniors feeling the squeeze : rising drug prices and the Part D program : hearing before the Special Committee on Aging, United States Senate, One Hundred Eleventh Congress, second session, Washington, DC, March 17, 2010
- Short-supply prescription drugs : shining a light on the gray market : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Twelfth Congress, second session, July 25, 2012
- Skyrocketing prescription drug prices : hearings before the Special Committee on Aging, United States Senate, One Hundred First Congress, first session, Washington, DC ... July 18, 1989 ... November 16, 1889
- Skyrocketing prescription drug prices : turning a bad deal into a fair deal : a majority staff report of the Special Committee on Aging, United States Senate
- Special report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugs : the monopoly business model that harms patients, taxpayers, and the U.S. health system
- State of competition in the pharmacy benefits manager and pharmacy marketplaces : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, first session, November 17, 2015
- Strengthening and improving the Medicare program : hearing before the Committee on Finance, United States Senate, One Hundred Eighth Congress, first session, June 6, 2003
- The cost of prescription drugs : how the drug delivery system affects what patients pay : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, first session on the cost of prescription drugs : focusing on how the drug delivery system affects what patients pay
- The cost of prescription drugs for the uninsured elderly and legislative approaches
- The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period
- The effects of escalating drug costs on the elderly : hearing before the Special Committee on Aging, United States Senate, One Hundred Second Congress, second session : morning session, Macon, GA, April 22, 1992; afternoon session, Atlanta, GA, April 22, 1992
- The federal government's investment in new drug research and development : are we getting our money's worth? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, February 24, 1993
- The real voice
- The strategic response by pharmaceutical firms to the Medicaid Most-Favored-Customer rules
- Treating the opioid epidemic : the state of competition in the markets for addiction medication : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, second session, September 22, 2016
- VA and DOD health care : factors contributing to reduced pharmacy costs and continuing challenges
- Would Prescription Drug Importation Reduce U.S. Drug Spending : CBO Economic and Budget Issue Brief.
Embed
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.law.upenn.edu/resource/WweEHPUlCLs/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.law.upenn.edu/resource/WweEHPUlCLs/">Drugs -- Prices -- United States</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.law.upenn.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.law.upenn.edu/">Biddle Law Library- University of Pennsylvania Law School</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Concept Drugs -- Prices -- United States
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.law.upenn.edu/resource/WweEHPUlCLs/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.law.upenn.edu/resource/WweEHPUlCLs/">Drugs -- Prices -- United States</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.law.upenn.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.law.upenn.edu/">Biddle Law Library- University of Pennsylvania Law School</a></span></span></span></span></div>
